IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROCA, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.909
AS - Asia 2.106
EU - Europa 1.520
SA - Sud America 475
AF - Africa 34
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.847
CN - Cina 737
SG - Singapore 727
BR - Brasile 397
UA - Ucraina 376
DE - Germania 334
HK - Hong Kong 273
VN - Vietnam 144
IT - Italia 141
GB - Regno Unito 128
RU - Federazione Russa 128
FI - Finlandia 101
TR - Turchia 85
IE - Irlanda 76
PL - Polonia 64
FR - Francia 43
CA - Canada 38
CZ - Repubblica Ceca 36
AR - Argentina 33
IN - India 29
BD - Bangladesh 26
BE - Belgio 19
SE - Svezia 19
IQ - Iraq 17
JP - Giappone 15
EC - Ecuador 13
MX - Messico 13
NL - Olanda 13
ES - Italia 12
CO - Colombia 10
AT - Austria 9
SA - Arabia Saudita 9
ZA - Sudafrica 9
VE - Venezuela 8
AU - Australia 6
DZ - Algeria 6
ID - Indonesia 6
PY - Paraguay 6
IR - Iran 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
MA - Marocco 4
CL - Cile 3
LT - Lituania 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 9.055
Salva come PNG Salva come JPEG
Città #
Fairfield 755
Ashburn 426
Woodbridge 391
Singapore 325
Jacksonville 316
Houston 309
Seattle 290
Hong Kong 270
Cambridge 257
Wilmington 248
Beijing 204
Chandler 202
Ann Arbor 179
Princeton 146
New York 108
Nanjing 102
Helsinki 79
Dublin 76
Los Angeles 72
Istanbul 69
Dearborn 64
The Dalles 63
Warsaw 62
Munich 55
Ho Chi Minh City 45
Des Moines 41
Dallas 40
Nanchang 36
Changsha 35
São Paulo 34
Moscow 33
Chicago 30
Hebei 29
San Diego 29
Brescia 28
Shanghai 28
Redondo Beach 27
San Francisco 26
Hanoi 25
Shenyang 25
Buffalo 24
Brno 22
London 20
Boardman 19
Brussels 19
Jinan 19
Turku 19
San Mateo 18
Atlanta 16
Tianjin 16
Montreal 15
Olomouc 14
Toronto 14
Brooklyn 13
Tokyo 13
Zhengzhou 13
Boston 12
Denver 12
Jiaxing 12
Nürnberg 12
Orem 12
Kunming 11
Santa Clara 11
Stockholm 11
Belo Horizonte 10
Dhaka 10
Dong Ket 10
Poplar 10
Rio de Janeiro 10
Falls Church 8
Guangzhou 8
Hangzhou 8
Lanzhou 8
Ningbo 8
Taizhou 8
Washington 8
Augusta 7
Milan 7
Nuremberg 7
Betim 6
Campinas 6
Chennai 6
Council Bluffs 6
Da Nang 6
Haiphong 6
Jeddah 6
Kilburn 6
Lancaster 6
Manaus 6
Napoli 6
Amsterdam 5
Ardabil 5
Biên Hòa 5
Charlotte 5
Frankfurt am Main 5
Haikou 5
Hefei 5
Manchester 5
Mexico City 5
Pelotas 5
Totale 6.189
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 231
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 198
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 192
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 191
Acute functional reactivation of the language network during awake intraoperative brain mapping 188
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 185
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 181
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 177
Regression of advanced neuroendocrine tumors among patients receiving placebo 176
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 176
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 176
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 174
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 171
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 169
Palbociclib inhibits proliferation of human adrenocortical tumor cells 168
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 167
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 167
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 161
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 160
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 160
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 156
Serum vitamin D and prostate cancer prognosis: The story continues 155
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 153
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 153
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 151
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 151
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 145
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 142
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 142
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 141
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 139
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 139
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 137
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 135
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 135
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 133
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 132
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 131
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 130
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 125
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 121
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 116
Malignant pleural mesothelioma: from the bench to the bedside 114
CT scanner for the pleural staging of pleural cancer: How accurate is this? 114
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 110
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 108
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 107
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 101
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 101
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 101
Malignant pleural mesothelioma signs and symptoms 100
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 99
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 96
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 93
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 89
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 89
Pathologie pleurale 83
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 80
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 66
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 61
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 61
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 60
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 60
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 59
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 59
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 58
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 58
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 55
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 55
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 55
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 55
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 43
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 37
Totale 9.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021794 0 0 0 0 0 115 47 134 110 164 156 68
2021/2022592 38 66 33 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/20251.323 20 5 8 199 145 93 117 53 183 74 259 167
2025/20261.730 262 440 240 426 321 41 0 0 0 0 0 0
Totale 9.212